The 2nd World Conference of Immuno-Oncology-2019 (WCIO-2019)
About WCIO-2019
The 2nd World Conference of Immuno-Oncology-2019 (WCIO-2019) will take place during October 11-13, 2019 in Dalian, China. This year’s theme is New Solutions to Curing Cancers.
WCIO-2019 will consists of two cooperative, specialized programs tailored to highlight the latest and most exciting discoveries in every area of cancer Immunotherapy research, and it will provide a unique opportunity for researchers from all over the world to meet, network, and forge new scientific interactions. Given the major worldwide importance in cancer Immunotherapy, we should not only help ensure we’re apprised of current developments in the field but also reflect on new progress and look toward future challenges.
WCIO has served as a catalyst to advance discovery and disseminate information about scientific advances. Wish you enjoy the conference.
Program at a Glance
Stream 1

Plenary Keynote Forums & Special Events

Stream 2

Frontiers of Immuno-Oncology

Stream 3

Breaking Cancer Immunotherapy

Stream 4

I-O Venture and Career Growth

Stream 5

IO Training Seminars and Workshops

Stream 6

Posters & Exhibition

Stream 7

Young Chinese IO Scientist Forums

Stream 8

Culture and Social Activities

Previous Renowned Speakers
Dr. Michael Hanna Jr.,Founder & Chairman Emeritus, Vaccinogen, Inc., USA 复件 复件 新建 BMP 图像.bmp Dr. Shimon Slavin, Professor & Medical Director, The International Center for Cell Therapy & Cancer Immunotherapy (CTCI), Israel 复件 复件 新建 BMP 图像.bmp Dr. Kostas Kosmatopoulos, 
Chief Executive Officer, Vaxon Biotech, France
Charles_Mills2 Dr. Charles D. Mills, Director, BioMedical Consultants, USA 1541e18 Dr. Stefan Glück, 
Professor of Medicine; Vice President, Global Medical Affairs, Celgene Corporation, USA
Dr. Kari Syrjanen, 
Chief Medical Director, Biohit Oyj, Finland
复件 复件 新建 BMP 图像.bmp Dr. Samuel C Wagner, Founder, President & Chief Executive Officer, Batu Biologics, Inc., USA 复件 复件 新建 BMP 图像.bmp Dr. Thomas Ichim, 
Founder & Chief Scientific Officer, Batu Biologics, Inc., USA Dr. Michael J. Gresser, CSO, ImmunGene, Inc., USA
复件 复件 新建 BMP 图像.bmp Dr. Jiong Wu, 
CEO, Superview Biotechnology, Co., Ltd., China
Dr. Barbara Seliger,Professor, Martin Luther University, Germany Dr. Gregory Lee, 
Professor, UBC Center for Reproductive Health, Canada Dr. Xiaoyang Qi, 
Professor of Medicine, University of Cincinnati College of Medicine, USA Dr. Thomas Schneider, Head of the Department, St Vincentius Kliniken, Gemanry Dr. Susumu Terakawa, 
Vice President & Professor, Medical Photonics Research Center, Hamamatsu University School of Medicine, Japan Dr. Geert Mudde,
Founder and CSO, OncoQR ML, Austria Dr. Peter Hersey, Professor, Kolling Institute University of Sydney, Australia Dr. Senyon Choe,
Professor, UCSD & Director, Mogam Institute, USA
Introduction to Dalian
Dalian — the "Northern Pearl" and summer resort of China, compared to ancient capital cities such as Beijing, Xian, Nanjing or Xi’an, is a young city with only a 100-year history. Dalian is the most relaxed and livable city in Northeast China. In many parts of China, economic prosperity comes at the price of clean air and charm. Not so in Dalian, whose natural blessings are its biggest asset. Tree-lined, hilly streets, dotted colonial architectures, an impressive coastline with beaches, as well as its prosperous town, have made it being dubbed as the "Hong Kong of the North China". It is one of the three Best Tourism Cities (2006), along with Hangzhou and Chengdu, recognized by the National Tourism Administration.
News Release

● Call for Session Chairs, Speakers and Attendees
● Call for Collaborative Partners, Medias and Journals
● Speaking Proposals are Now being Accepted, Submit the Abstract Right Now
REGISTER NOW to secure your attendance and enjoy favorable discount

Hosting Organization
Information Research Center of International Talent, State Administration of Foreign Experts Affairs, China
Operating Organization

BIT Group Global Ltd
Official Travel Agency
BIT's Upcoming Events

© 2018-2019 All rights reserved by BIT Group Global Ltd.
Contact Us: Tel: 0086-411-84799609, Fax: 0086-411-84796897